Evidence map›Paper›PMID 35880248›Full record

ArticleCancer science2022

Establishment of a deep-learning system to diagnose BI-RADS4a or higher using breast ultrasound for clinical application.

Tetsu Hayashida, Erina Odani, Masayuki Kikuchi, Aiko Nagayama, Tomoko Seki, Maiko Takahashi, Noriyuki Futatsugi, Akiko Matsumoto, Takeshi Murata, Rurina Watanuki and 12 more

Abstract read
In one paragraph

Article in Cancer science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Tetsu HayashidaDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0002-1657-803X
Erina OdaniDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.
Masayuki KikuchiDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.
Aiko NagayamaDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.
Tomoko SekiDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.
Maiko TakahashiDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.
Noriyuki FutatsugiFixstars Corporation, Tokyo, Japan.
Akiko MatsumotoDepartment of Surgery, Teikyo University School of Medicine, Tokyo, Japan.
Takeshi MurataDepartment of Breast Surgery, National Cancer Center Hospital, Tokyo, Japan.
Rurina WatanukiDepartment of Breast Surgery, National Cancer Center Hospital East, Chiba, Japan.
Takamichi YokoeDepartment of Breast Surgery, National Cancer Center Hospital East, Chiba, Japan.
Ayako NakashojiDepartment of Breast Surgery, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
Hinako MaedaDepartment of Breast and Thyroid Surgery, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.
Tatsuya OnishiDepartment of Breast Surgery, National Cancer Center Hospital East, Chiba, Japan.
Sota AsagaDepartment of Breast Surgery, Kyorin University School of Medicine, Tokyo, Japan.
Takashi HojoDepartment of Breast Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
Hiromitsu JinnoDepartment of Surgery, Teikyo University School of Medicine, Tokyo, Japan.
Keiichi SotomeDepartment of Breast and Thyroid Surgery, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.
Akira MatsuiDepartment of Breast Surgery, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
Akihiko SutoDepartment of Breast Surgery, National Cancer Center Hospital, Tokyo, Japan.
Shigeru ImotoDepartment of Breast Surgery, Kyorin University School of Medicine, Tokyo, Japan.
Yuko KitagawaDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.

Funding

Fixstars CorporationJSPS KAKENHI Grant-in-Aid for Scientific Research (C) 20K08993
6 · The paper itself

Abstract

Although the categorization of ultrasound using the Breast Imaging Reporting and Data System (BI-RADS) has become widespread worldwide, the problem of inter-observer variability remains. To maintain uniformity in diagnostic accuracy, we have developed a system in which artificial intelligence (AI) can distinguish whether a static image obtained using a breast ultrasound represents BI-RADS3 or lower or BI-RADS4a or higher to determine the medical management that should be performed on a patient whose breast ultrasound shows abnormalities. To establish and validate the AI system, a training dataset consisting of 4028 images containing 5014 lesions and a test dataset consisting of 3166 images containing 3656 lesions were collected and annotated. We selected a setting that maximized the area under the curve (AUC) and minimized the difference in sensitivity and specificity by adjusting the internal parameters of the AI system, achieving an AUC, sensitivity, and specificity of 0.95, 91.2%, and 90.7%, respectively. Furthermore, based on 30 images extracted from the test data, the diagnostic accuracy of 20 clinicians and the AI system was compared, and the AI system was found to be significantly superior to the clinicians (McNemar test, p < 0.001). Although deep-learning methods to categorize benign and malignant tumors using breast ultrasound have been extensively reported, our work represents the first attempt to establish an AI system to classify BI-RADS3 or lower and BI-RADS4a or higher successfully, providing important implications for clinical actions. These results suggest that the AI diagnostic system is sufficient to proceed to the next stage of clinical application.

Indexed as

Breast NeoplasmsDeep LearningArtificial IntelligenceFemaleHumansSensitivity and SpecificityUltrasonographyUltrasonography, MammaryAI diagnosisartificial intelligenceBI-RADSbreast ultrasounddeep learning

Identifiers

PMID35880248
PMCPMC9530860

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.